Literature DB >> 35402857

Health Product Manufacturers and Innovators COVID-19 Impact Assessment: Lessons Learned and Compelling Needs.

Mathai Mammen1, Vasant Narasimhan2, Richard Kuntz3, Freda Lewis-Hall4, Mojdeh Poul5, Adam Schechter6.   

Abstract

Entities:  

Year:  2022        PMID： 35402857      PMCID： PMC8970224          DOI： 10.31478/202201b

Source DB:  PubMed          Journal:  NAM Perspect        ISSN： 2578-6865


× No keyword cloud information.
  20 in total

1.  Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.

Authors:  Steven Joffe
Journal:  JAMA       Date:  2021-01-19       Impact factor: 56.272

2.  When will clinical trials finally reflect diversity?

Authors:  Todd C Knepper; Howard L McLeod
Journal:  Nature       Date:  2018-05       Impact factor: 49.962

3.  Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust.

Authors:  Brit Trogen; David Oshinsky; Arthur Caplan
Journal:  JAMA       Date:  2020-06-23       Impact factor: 56.272

4.  Emerging Lessons From COVID-19 for the US Clinical Research Enterprise.

Authors:  Derek C Angus; Anthony C Gordon; Howard Bauchner
Journal:  JAMA       Date:  2021-03-23       Impact factor: 56.272

5.  Deferral of Care for Serious Non-COVID-19 Conditions: A Hidden Harm of COVID-19.

Authors:  Colette DeJong; Mitchell H Katz; Kenneth Covinsky
Journal:  JAMA Intern Med       Date:  2021-02-01       Impact factor: 44.409

6.  Characteristics Associated with Hospitalization Among Patients with COVID-19 - Metropolitan Atlanta, Georgia, March-April 2020.

Authors:  Marie E Killerby; Ruth Link-Gelles; Sarah C Haight; Caroline A Schrodt; Lucinda England; Danica J Gomes; Mays Shamout; Kristen Pettrone; Kevin O'Laughlin; Anne Kimball; Erin F Blau; Eleanor Burnett; Chandresh N Ladva; Christine M Szablewski; Melissa Tobin-D'Angelo; Nadine Oosmanally; Cherie Drenzek; David J Murphy; James M Blum; Julie Hollberg; Benjamin Lefkove; Frank W Brown; Tom Shimabukuro; Claire M Midgley; Jacqueline E Tate
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-06-26       Impact factor: 17.586

7.  Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States.

Authors:  Jennifer Harcourt; Azaibi Tamin; Xiaoyan Lu; Shifaq Kamili; Senthil K Sakthivel; Janna Murray; Krista Queen; Ying Tao; Clinton R Paden; Jing Zhang; Yan Li; Anna Uehara; Haibin Wang; Cynthia Goldsmith; Hannah A Bullock; Lijuan Wang; Brett Whitaker; Brian Lynch; Rashi Gautam; Craig Schindewolf; Kumari G Lokugamage; Dionna Scharton; Jessica A Plante; Divya Mirchandani; Steven G Widen; Krishna Narayanan; Shinji Makino; Thomas G Ksiazek; Kenneth S Plante; Scott C Weaver; Stephen Lindstrom; Suxiang Tong; Vineet D Menachery; Natalie J Thornburg
Journal:  Emerg Infect Dis       Date:  2020-06-17       Impact factor: 6.883

8.  Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States - The NIH RADx Initiative.

Authors:  Bruce J Tromberg; Tara A Schwetz; Eliseo J Pérez-Stable; Richard J Hodes; Richard P Woychik; Rick A Bright; Rachael L Fleurence; Francis S Collins
Journal:  N Engl J Med       Date:  2020-07-22       Impact factor: 91.245

9.  Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic.

Authors:  Harvey W Kaufman; Zhen Chen; Justin Niles; Yuri Fesko
Journal:  JAMA Netw Open       Date:  2020-08-03

10.  Under a Black Cloud Glimpsing a Silver Lining: Comment on Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic.

Authors:  Rob Hemmings
Journal:  Stat Biopharm Res       Date:  2020-07-14       Impact factor: 1.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.